Skip to content
2000
Volume 19, Issue 4
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Background: Peniciketal A (Pe-A), a spiroketal compound, shows potent anticancer activities in human acute monocytic leukemia. However, the detailed mechanisms and potent targets of Pe-A remain largely unexplored. Here, we investigated the differentially expressed proteins between the Pe-A-treated group and the control group on human acute monocytic leukemia cell line THP-1. Methods: The DEPs were analyzed by the liquid chromatography-tandem mass spectrometry (LC-MS/MS) with TMT label. The function and feature of the identified proteins were analyzed by the bioinformatic analysis. Western blotting was used to evaluate protein expression. Results: The DEPs were primarily sub located in the cytoplasm and the nucleus by regulating 21 pathways enriched through the Kyoto Encyclopedia of Genes and Genomes (KEGG). Moreover, we preliminarily demonstrated that glucose-6-phosphate 1-dehydrogenase (G6PD), prolow-density lipoprotein receptor-related protein 1 (LRP1) and Calreticulin (CALR) might be the potent targets of Pe-A on death induction of THP-1 cells. Conclusion: Collectively, this study not only provides a global proteomic profile as the supplementary data of our previous studies but also provides interesting information that Pe-A may exert more bio-activities.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520619666190212124339
2019-03-01
2025-07-09
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520619666190212124339
Loading

  • Article Type:
    Research Article
Keyword(s): apoptosis; autophagy; LS-MS/MS; monocytic leukemia; Peniciketal A; proteomic analysis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test